Harbin Pharmaceutical Group Co Ltd (600664) — Capital Reinvestment Ratio
Harbin Pharmaceutical Group Co Ltd (600664) has a Capital Reinvestment Ratio of 0.06x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥323.33 Million) in capital expenditures (CN¥20.49 Million). Check 600664 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Harbin Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (1998–2024)
This chart tracks Harbin Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 23 annual periods. For the full cash flow conversion analysis, see Harbin Pharmaceutical Group Co Ltd cash conversion from operations.
Annual Capital Reinvestment Ratio for Harbin Pharmaceutical Group Co Ltd (1998–2024)
Year-by-year Capital Reinvestment Ratio for Harbin Pharmaceutical Group Co Ltd from 1998 to 2024. See Harbin Pharmaceutical Group Co Ltd (600664) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.13x | CN¥792.50 Million | CN¥100.81 Million | ▲ +39.6% |
| 2023 | 0.09x | CN¥949.67 Million | CN¥86.54 Million | ▼ -36.8% |
| 2022 | 0.14x | CN¥622.09 Million | CN¥89.65 Million | ▼ -12.5% |
| 2018 | 0.16x | CN¥692.72 Million | CN¥114.11 Million | ▼ -75.9% |
| 2017 | 0.68x | CN¥149.22 Million | CN¥102.01 Million | ▲ +1667.3% |
| 2016 | 0.04x | CN¥2.78 Billion | CN¥107.46 Million | ▼ -77.9% |
| 2015 | 0.18x | CN¥1.66 Billion | CN¥290.75 Million | ▼ -47.0% |
| 2014 | 0.33x | CN¥1.14 Billion | CN¥375.37 Million | ▼ -87.3% |
| 2013 | 2.61x | CN¥141.64 Million | CN¥369.90 Million | ▲ +428.2% |
| 2012 | 0.49x | CN¥557.83 Million | CN¥275.78 Million | ▲ +90.5% |
| 2010 | 0.26x | CN¥1.15 Billion | CN¥299.19 Million | ▲ +115.3% |
| 2009 | 0.12x | CN¥1.85 Billion | CN¥223.26 Million | ▼ -51.2% |
| 2008 | 0.25x | CN¥578.59 Million | CN¥143.09 Million | ▼ -8.1% |
| 2007 | 0.27x | CN¥650.16 Million | CN¥175.00 Million | ▼ -39.1% |
| 2006 | 0.44x | CN¥738.08 Million | CN¥326.28 Million | ▼ -24.5% |
| 2005 | 0.59x | CN¥757.76 Million | CN¥443.61 Million | ▼ -79.6% |
| 2004 | 2.88x | CN¥149.01 Million | CN¥428.60 Million | ▲ +83.9% |
| 2003 | 1.56x | CN¥302.83 Million | CN¥473.73 Million | ▲ +53.4% |
| 2002 | 1.02x | CN¥383.44 Million | CN¥391.03 Million | ▼ -3.0% |
| 2001 | 1.05x | CN¥604.13 Million | CN¥635.28 Million | ▼ -2.2% |
| 2000 | 1.08x | CN¥541.70 Million | CN¥582.49 Million | ▲ +151.4% |
| 1999 | 0.43x | CN¥431.22 Million | CN¥184.43 Million | ▼ -6.0% |
| 1998 | 0.45x | CN¥221.41 Million | CN¥100.73 Million | — |